{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T12:02:47Z","timestamp":1770984167799,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T00:00:00Z","timestamp":1652054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eat Weight Disord"],"DOI":"10.1007\/s40519-022-01400-y","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T03:23:46Z","timestamp":1652066626000},"page":"2617-2627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Concordance between indirect fibrosis and steatosis indices and their predictors in subjects with overweight\/obesity"],"prefix":"10.1007","volume":"27","author":[{"given":"Gaggini","family":"Melania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vigna","family":"Luisella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di Piazza","family":"Salvina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gori","family":"Francesca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tirelli","family":"Amedea Silvia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bamonti","family":"Fabrizia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maltinti","family":"Maristella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Napolitano","family":"Filomena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chatzianagnostou","family":"Kyriazoula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3438-6450","authenticated-orcid":false,"given":"Cristina","family":"Vassalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,9]]},"reference":[{"key":"1400_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30794-3","author":"JJ Reilly","year":"2018","unstructured":"Reilly JJ, El-Hamdouchi A, Diouf A et al (2018) Determining the worldwide prevalence of obesity. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(18)30794-3","journal-title":"Lancet"},{"key":"1400_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05140-5","author":"TM Schnurr","year":"2020","unstructured":"Schnurr TM, Jakupovi\u0107 H, Carrasquilla GD et al (2020) Obesity, unfavourable lifestyle and genetic risk of type 2 diabetes: a case-cohort study. Diabetologia. https:\/\/doi.org\/10.1007\/s00125-020-05140-5","journal-title":"Diabetologia"},{"key":"1400_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK et al (2020) A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039","journal-title":"J Hepatol"},{"key":"1400_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.06.021","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Golabi P, de Avila L et al (2019) The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2019.06.021","journal-title":"J Hepatol"},{"key":"1400_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.05.036","author":"C Estes","year":"2018","unstructured":"Estes C, Anstee QM, Arias-Loste MT et al (2018) Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.036","journal-title":"J Hepatol"},{"key":"1400_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/ncp.10449","author":"MS Mundi","year":"2020","unstructured":"Mundi MS, Velapati S, Patel J et al (2020) Evolution of NAFLD and Its management. Nutr Clin Pract. https:\/\/doi.org\/10.1002\/ncp.10449","journal-title":"Nutr Clin Pract"},{"key":"1400_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.07.020","author":"JM Schattenberg","year":"2020","unstructured":"Schattenberg JM, Straub BK (2020) On the value and limitations of liver histology in assessing non-alcoholic steatohepatitis. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2020.07.020","journal-title":"J Hepatol"},{"key":"1400_CR8","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2019.0011","author":"Y Lee","year":"2019","unstructured":"Lee Y, Cho Y, Lee BW et al (2019) Nonalcoholic fatty liver disease in diabetes. Part I: epidemiology and diagnosis. Diabetes Metab J. https:\/\/doi.org\/10.4093\/dmj.2019.0011","journal-title":"Diabetes Metab J"},{"key":"1400_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.05.025","author":"A Berzigotti","year":"2021","unstructured":"Berzigotti A, Tsochatzis E, Boursier J et al (2021) EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u20142021 update. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2021.05.025","journal-title":"J Hepatol"},{"key":"1400_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-000904","author":"S Ciardullo","year":"2020","unstructured":"Ciardullo S, Muraca E, Perra S et al (2020) Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications. BMJ Open Diabetes Res Care. https:\/\/doi.org\/10.1136\/bmjdrc-2019-000904","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1400_CR11","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001054","author":"ZM Younossi","year":"2021","unstructured":"Younossi ZM, Noureddin M, Bernstein D et al (2021) Role of noninvasive tests in clinical gastroenterology practices to identify patients with nonalcoholic steatohepatitis at high risk of adverse outcomes: expert panel recommendations. Am J Gastroenterol. https:\/\/doi.org\/10.14309\/ajg.0000000000001054","journal-title":"Am J Gastroenterol"},{"key":"1400_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14043","author":"K Chatzianagnostou","year":"2019","unstructured":"Chatzianagnostou K, Vigna L, Di PS et al (2019) Low concordance between HbA1c and OGTT to diagnose prediabetes and diabetes in overweight or obesity. Clin Endocrinol (Oxf). https:\/\/doi.org\/10.1111\/cen.14043","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1400_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s13679-015-0153-z","author":"R Puhl","year":"2015","unstructured":"Puhl R, Suh Y (2015) Health consequences of weight stigma: implications for obesity prevention and treatment. Curr Obes Rep. https:\/\/doi.org\/10.1007\/s13679-015-0153-z","journal-title":"Curr Obes Rep"},{"key":"1400_CR14","doi-asserted-by":"publisher","DOI":"10.1037\/amp0000538","author":"RM Puhl","year":"2020","unstructured":"Puhl RM, Himmelstein MS, Pearl RL (2020) Weight stigma as a psychosocial contributor to obesity. Am Psychol. https:\/\/doi.org\/10.1037\/amp0000538","journal-title":"Am Psychol"},{"key":"1400_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20734","author":"G Bedogni","year":"2005","unstructured":"Bedogni G, Miglioli L, Masutti F et al (2005) Prevalence of and risk factors for nonalcoholic fatty liver disease: the dionysos nutrition and liver study. Hepatology. https:\/\/doi.org\/10.1002\/hep.20734","journal-title":"Hepatology"},{"key":"1400_CR16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.06.005","author":"A Kotronen","year":"2009","unstructured":"Kotronen A, Peltonen M, Hakkarainen A et al (2009) Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology. https:\/\/doi.org\/10.1053\/j.gastro.2009.06.005","journal-title":"Gastroenterology"},{"key":"1400_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N et al (2006) Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. https:\/\/doi.org\/10.1002\/hep.21178","journal-title":"Hepatology"},{"key":"1400_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.146019","author":"SA Harrison","year":"2008","unstructured":"Harrison SA, Oliver D, Arnold HL et al (2008) Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. https:\/\/doi.org\/10.1136\/gut.2007.146019","journal-title":"Gut"},{"key":"1400_CR19","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.36128","author":"X Forns","year":"2002","unstructured":"Forns X, Ampurdan\u00e8s S, Llovet JM et al (2002) Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. https:\/\/doi.org\/10.1053\/jhep.2002.36128","journal-title":"Hepatology"},{"key":"1400_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)70364-7","author":"V Ratziu","year":"2000","unstructured":"Ratziu V, Giral P, Charlotte F et al (2000) Liver fibrosis in overweight patients. Gastroenterology. https:\/\/doi.org\/10.1016\/S0016-5085(00)70364-7","journal-title":"Gastroenterology"},{"key":"1400_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-2980.2012.00631","author":"YH Xun","year":"2012","unstructured":"Xun YH, Fan JG, Zang GQ et al (2012) Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease. J Dig Dis. https:\/\/doi.org\/10.1111\/j.1751-2980.2012.00631","journal-title":"J Dig Dis"},{"key":"1400_CR22","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1136\/gut.2010.216077","volume":"59","author":"S McPherson","year":"2010","unstructured":"McPherson S, Stewart SF, Henderson E et al (2010) Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut 59:1265\u20131269. https:\/\/doi.org\/10.1136\/gut.2010.216077","journal-title":"Gut"},{"key":"1400_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2016.1264280","author":"L Vigna","year":"2017","unstructured":"Vigna L, Cassinelli L, Tirelli AS et al (2017) 25(OH)D levels in relation to gender, overweight, insulin resistance, and inflammation in a cross-sectional cohort of northern italian workers: evidence in support of preventive health care programs. J Am Coll Nutr. https:\/\/doi.org\/10.1080\/07315724.2016.1264280","journal-title":"J Am Coll Nutr"},{"key":"1400_CR24","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2010.518623","author":"G Musso","year":"2011","unstructured":"Musso G, Gambino R, Cassader M, Pagano G (2011) Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. https:\/\/doi.org\/10.3109\/07853890.2010.518623","journal-title":"Ann Med"},{"key":"1400_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21669","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B et al (2007) FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and FibroTest. Hepatology. https:\/\/doi.org\/10.1002\/hep.21669","journal-title":"Hepatology"},{"key":"1400_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.05.033","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K et al (2009) Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. https:\/\/doi.org\/10.1016\/j.cgh.2009.05.033","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1400_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-007-9924-z","author":"JR Mera","year":"2008","unstructured":"Mera JR, Dickson B, Feldman M (2008) Influence of gender on the ratio of serum aspartate aminotransferase (AST) to alanine aminotransferase (ALT) in patients with and without hyperbilirubinemia. Dig Dis Sci. https:\/\/doi.org\/10.1007\/s10620-007-9924-z","journal-title":"Dig Dis Sci"},{"key":"1400_CR28","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2010.216077","author":"S McPherson","year":"2010","unstructured":"McPherson S, Stewart SF, Henderson E et al (2010) Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. https:\/\/doi.org\/10.1136\/gut.2010.216077","journal-title":"Gut"},{"key":"1400_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.173","author":"G Targher","year":"2018","unstructured":"Targher G, Lonardo A, Byrne CD (2018) Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus. Nat Rev Endocrinol. https:\/\/doi.org\/10.1038\/nrendo.2017.173","journal-title":"Nat Rev Endocrinol"},{"key":"1400_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000905","author":"A Singh","year":"2018","unstructured":"Singh A, Le P, Peerzada MM et al (2018) The utility of noninvasive scores in assessing the prevalence of nonalcoholic fatty liver disease and advanced fibrosis in type 2 diabetic patients. J Clin Gastroenterol. https:\/\/doi.org\/10.1097\/MCG.0000000000000905","journal-title":"J Clin Gastroenterol"},{"key":"1400_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-020-01188-7","author":"S Ciardullo","year":"2020","unstructured":"Ciardullo S, Ronchetti C, Muraca E et al (2020) Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-020-01188-7","journal-title":"J Endocrinol Invest"},{"key":"1400_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28394","author":"C Cassinotto","year":"2016","unstructured":"Cassinotto C, Boursier J, de L\u00e9dinghen V et al (2016) Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology. https:\/\/doi.org\/10.1002\/hep.28394","journal-title":"Hepatology"},{"key":"1400_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2009.08.002","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ et al (2010) Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. https:\/\/doi.org\/10.1016\/j.dld.2009.08.002","journal-title":"Dig Liver Dis"},{"key":"1400_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24105","author":"ZH Lin","year":"2011","unstructured":"Lin ZH, Xin YN, Dong QJ et al (2011) Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. https:\/\/doi.org\/10.1002\/hep.24105","journal-title":"Hepatology"}],"container-title":["Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40519-022-01400-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40519-022-01400-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40519-022-01400-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T16:10:32Z","timestamp":1665591032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40519-022-01400-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,9]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["1400"],"URL":"https:\/\/doi.org\/10.1007\/s40519-022-01400-y","relation":{},"ISSN":["1590-1262"],"issn-type":[{"value":"1590-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,9]]},"assertion":[{"value":"4 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of Milan Policlinico Hospital (Study registration number: 1370).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}}]}}